PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238 | -43.6% | 10,599 | +2.0% | 0.02% | -45.5% |
| Q2 2023 | $422 | -0.2% | 10,387 | +19.0% | 0.03% | +6.5% |
| Q1 2023 | $423 | 0.0% | 8,732 | -21.2% | 0.03% | -11.4% |
| Q4 2022 | $423 | -99.9% | 11,083 | +24.8% | 0.04% | -16.7% |
| Q3 2022 | $446,000 | -17.9% | 8,881 | -34.5% | 0.04% | -14.3% |
| Q2 2022 | $543,000 | +86.0% | 13,553 | +73.1% | 0.05% | +390.0% |
| Q1 2022 | $292,000 | – | 7,830 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |